{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:51:02Z","timestamp":1792590662175,"version":"4.5.0"},"reference-count":60,"publisher":"MyJove Corporation","issue":"232","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/71827","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:00:18Z","timestamp":1780786818000},"source":"Crossref","is-referenced-by-count":0,"title":["Multi-Omics Pan-Cancer Bioinformatics Workflow for Evaluating PTDSS1 and PTDSS2 as Prognostic and Immune Biomarkers"],"prefix":"10.3791","author":[{"given":"Weiqiu","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12672-023-00802-3","type":"journal-article","article-title":"A risk score model based on lipid metabolism-related genes could predict response to immunotherapy and prognosis of lung adenocarcinoma: a multi-dataset study and cytological validation","volume":"14","author":"Lei","year":"2023","unstructured":"Lei Y, Zhou B, Meng X, Liang M, Song W, Liang Y, et al. A risk score model based on lipid metabolism-related genes could predict response to immunotherapy and prognosis of lung adenocarcinoma: a multi-dataset study and cytological validation. Discov Oncol. 2023;14(1):188.","journal-title":"Discov Oncol"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.71426\/jmt.v2.i1.pp292-301","type":"journal-article","article-title":"SmartBio: an AI-enabled smart medical device for early cancer detection using variational autoencoders and multimodal sensor integration","volume":"2","author":"Kara","year":"2025","unstructured":"Kara RV. SmartBio: an AI-enabled smart medical device for early cancer detection using variational autoencoders and multimodal sensor integration. J Mod Technol. 2025;2(1):292-301.","journal-title":"J Mod Technol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","type":"journal-article","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018;38(1):27.","journal-title":"Cancer Commun (Lond)"},{"issue":"630","key":"ref4","doi-asserted-by":"crossref","first-page":"eabk2756","DOI":"10.1126\/scitranslmed.abk2756","type":"journal-article","article-title":"Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis","volume":"14","author":"Wang","year":"2022","unstructured":"Wang G, Qiu M, Xing X, Zhou J, Yao H, Li M, et al. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis. Sci Transl Med. 2022;14(630):eabk2756.","journal-title":"Sci Transl Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.critrevonc.2017.02.001","type":"journal-article","article-title":"Lipid metabolism and lung cancer","volume":"112","author":"Merino Salvador","year":"2017","unstructured":"Merino Salvador M, G\u00f3mez de Cedr\u00f3n M, Moreno Rubio J, Falag\u00e1n Mart\u00ednez S, S\u00e1nchez Mart\u00ednez R, Casado E, et al. Lipid metabolism and lung cancer. Crit Rev Oncol Hematol. 2017;112:31-40.","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1050721","DOI":"10.3389\/fimmu.2022.1050721","type":"journal-article","article-title":"Evaluation of the ability of fatty acid metabolism signature to predict response to neoadjuvant chemoradiotherapy and prognosis of patients with locally advanced rectal cancer","volume":"13","author":"Zhou","year":"2022","unstructured":"Zhou H, Chen Y, Xiao Y, Wu Q, Li H, Li Y, et al. Evaluation of the ability of fatty acid metabolism signature to predict response to neoadjuvant chemoradiotherapy and prognosis of patients with locally advanced rectal cancer. Front Immunol. 2022;13:1050721.","journal-title":"Front Immunol"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1111\/jcmm.14647","type":"journal-article","article-title":"Prognostic power of a lipid metabolism gene panel for diffuse gliomas","volume":"23","author":"Wu","year":"2019","unstructured":"Wu F, Zhao Z, Chai RC, Liu YQ, Li GZ, Jiang HY, et al. Prognostic power of a lipid metabolism gene panel for diffuse gliomas. J Cell Mol Med. 2019;23(11):7741-8.","journal-title":"J Cell Mol Med"},{"issue":"1-2","key":"ref8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0005-2760(97)00137-9","type":"journal-article","article-title":"Phosphatidylserine synthase I and II of mammalian cells","volume":"1348","author":"Kuge","year":"1997","unstructured":"Kuge O, Nishijima M. Phosphatidylserine synthase I and II of mammalian cells. Biochim Biophys Acta. 1997;1348(1-2):151-6.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1194\/jlr.R700020-JLR200","type":"journal-article","article-title":"Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids","volume":"49","author":"Vance","year":"2008","unstructured":"Vance JE. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J Lipid Res. 2008;49(7):1377-87.","journal-title":"J Lipid Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.biophys.093008.131234","type":"journal-article","article-title":"The distribution and function of phosphatidylserine in cellular membranes","volume":"39","author":"Leventis","year":"2010","unstructured":"Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys. 2010;39:407-27.","journal-title":"Annu Rev Biophys"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1083\/jcb.201005100","type":"journal-article","article-title":"Phosphatidylserine is a critical modulator for Akt activation","volume":"192","author":"Huang","year":"2011","unstructured":"Huang BX, Akbar M, Kevala K, Kim HY. Phosphatidylserine is a critical modulator for Akt activation. J Cell Biol. 2011;192(6):979-92.","journal-title":"J Cell Biol"},{"issue":"35","key":"ref12","doi-asserted-by":"crossref","first-page":"24184","DOI":"10.1016\/S0021-9258(18)54410-0","type":"journal-article","article-title":"A Chinese hamster cDNA encoding a protein essential for phosphatidylserine synthase I activity","volume":"266","author":"Kuge","year":"1991","unstructured":"Kuge O, Nishijima M, Akamatsu Y. A Chinese hamster cDNA encoding a protein essential for phosphatidylserine synthase I activity. J Biol Chem. 1991;266(35):24184-9.","journal-title":"J Biol Chem"},{"issue":"31","key":"ref13","doi-asserted-by":"crossref","first-page":"19133","DOI":"10.1074\/jbc.272.31.19133","type":"journal-article","article-title":"Cloning of a Chinese hamster ovary (CHO) cDNA encoding phosphatidylserine synthase (PSS) II, overexpression of which suppresses the phosphatidylserine biosynthetic defect of a PSS I-lacking mutant of CHO-K1 cells","volume":"272","author":"Kuge","year":"1997","unstructured":"Kuge O, Saito K, Nishijima M. Cloning of a Chinese hamster ovary (CHO) cDNA encoding phosphatidylserine synthase (PSS) II, overexpression of which suppresses the phosphatidylserine biosynthetic defect of a PSS I-lacking mutant of CHO-K1 cells. J Biol Chem. 1997;272(31):19133-9.","journal-title":"J Biol Chem"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","type":"journal-article","article-title":"Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells","volume":"1831","author":"Vance","year":"2013","unstructured":"Vance JE, Tasseva G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim Biophys Acta. 2013;1831(3):543-54.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1074\/jbc.M707653200","type":"journal-article","article-title":"Analysis and molecular modeling of the formation, structure, and activity of the phosphatidylserine-calcium-phosphate complex associated with biomineralization","volume":"283","author":"Wu","year":"2008","unstructured":"Wu LN, Genge BR, Wuthier RE. Analysis and molecular modeling of the formation, structure, and activity of the phosphatidylserine-calcium-phosphate complex associated with biomineralization. J Biol Chem. 2008;283(7):3827-38.","journal-title":"J Biol Chem"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/ajmg.a.62695","type":"journal-article","article-title":"De novo loss-of-function variant in PTDSS1 is associated with developmental delay","volume":"188","author":"Gracie","year":"2022","unstructured":"Gracie S, Sengupta N, Ferreira C, Pemberton J, Anderson I, Wang X, et al. De novo loss-of-function variant in PTDSS1 is associated with developmental delay. Am J Med Genet A. 2022;188(6):1739-45.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0021-9258(17)36044-1","type":"journal-article","article-title":"Isolation and characterization of a Chinese hamster ovary cell line requiring ethanolamine or phosphatidylserine for growth and exhibiting defective phosphatidylserine synthase activity","volume":"261","author":"Voelker","year":"1986","unstructured":"Voelker DR, Frazier JL. Isolation and characterization of a Chinese hamster ovary cell line requiring ethanolamine or phosphatidylserine for growth and exhibiting defective phosphatidylserine synthase activity. J Biol Chem. 1986;261(3):1002-8.","journal-title":"J Biol Chem"},{"issue":"13","key":"ref18","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1016\/S0021-9258(17)38452-1","type":"journal-article","article-title":"Phosphatidylserine biosynthesis in cultured Chinese hamster ovary cells. III. Genetic evidence for utilization of phosphatidylcholine and phosphatidylethanolamine as precursors","volume":"261","author":"Kuge","year":"1986","unstructured":"Kuge O, Nishijima M, Akamatsu Y. Phosphatidylserine biosynthesis in cultured Chinese hamster ovary cells. III. Genetic evidence for utilization of phosphatidylcholine and phosphatidylethanolamine as precursors. J Biol Chem. 1986;261(13):5795-8.","journal-title":"J Biol Chem"},{"issue":"49","key":"ref19","doi-asserted-by":"crossref","first-page":"47701","DOI":"10.1074\/jbc.M207734200","type":"journal-article","article-title":"Defining the importance of phosphatidylserine synthase 2 in mice","volume":"277","author":"Bergo","year":"2002","unstructured":"Bergo MO, Gavino BJ, Steenbergen R, Sturbois B, Parlow AF, Sanan DA, et al. Defining the importance of phosphatidylserine synthase 2 in mice. J Biol Chem. 2002;277(49):47701-8.","journal-title":"J Biol Chem"},{"issue":"27","key":"ref20","doi-asserted-by":"crossref","first-page":"17199","DOI":"10.1074\/jbc.273.27.17199","type":"journal-article","article-title":"Genetic evidence that phosphatidylserine synthase II catalyzes the conversion of phosphatidylethanolamine to phosphatidylserine in Chinese hamster ovary cells","volume":"273","author":"Saito","year":"1998","unstructured":"Saito K, Nishijima M, Kuge O. Genetic evidence that phosphatidylserine synthase II catalyzes the conversion of phosphatidylethanolamine to phosphatidylserine in Chinese hamster ovary cells. J Biol Chem. 1998;273(27):17199-205.","journal-title":"J Biol Chem"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1074\/jbc.M009776200","type":"journal-article","article-title":"Structure and expression of the murine phosphatidylserine synthase-1 gene","volume":"276","author":"Sturbois-Balcerzak","year":"2001","unstructured":"Sturbois-Balcerzak B, Stone SJ, Sreenivas A, Vance JE. Structure and expression of the murine phosphatidylserine synthase-1 gene. J Biol Chem. 2001;276(11):8205-12.","journal-title":"J Biol Chem"},{"issue":"19","key":"ref22","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1074\/jbc.M800714200","type":"journal-article","article-title":"Defining the importance of phosphatidylserine synthase-1 (PSS1): unexpected viability of PSS1-deficient mice","volume":"283","author":"Arikketh","year":"2008","unstructured":"Arikketh D, Nelson R, Vance JE. Defining the importance of phosphatidylserine synthase-1 (PSS1): unexpected viability of PSS1-deficient mice. J Biol Chem. 2008;283(19):12888-97.","journal-title":"J Biol Chem"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1158\/0008-5472.CAN-20-3870","type":"journal-article","article-title":"Phosphatidylserine synthase PTDSS1 shapes the tumor lipidome to maintain tumor-promoting inflammation","volume":"82","author":"Sekar","year":"2022","unstructured":"Sekar D, Dillmann C, Sirait-Fischer E, Fink AF, Zivkovic A, Baum N, et al. Phosphatidylserine synthase PTDSS1 shapes the tumor lipidome to maintain tumor-promoting inflammation. Cancer Res. 2022;82(8):1617-32.","journal-title":"Cancer Res"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1002\/imt2.36","type":"journal-article","article-title":"Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform","volume":"1","author":"Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1(3):e36.","journal-title":"iMeta"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41591-022-02193-4","type":"journal-article","article-title":"Bodywide ecological interventions on cancer","volume":"29","author":"Kroemer","year":"2023","unstructured":"Kroemer G, McQuade JL, Merad M, Andr\u00e9 F, Zitvogel L. Bodywide ecological interventions on cancer. Nat Med. 2023;29(1):59-74.","journal-title":"Nat Med"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","type":"journal-article","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","unstructured":"Morris EC, Neelapu SS, Giavridis T, Sadelain M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat Rev Immunol. 2022;22(2):85-96.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s12272-015-0628-1","type":"journal-article","article-title":"Existing drugs and their application in drug discovery targeting cancer stem cells","volume":"38","author":"Lv","year":"2015","unstructured":"Lv J, Shim JS. Existing drugs and their application in drug discovery targeting cancer stem cells. Arch Pharm Res. 2015;38(9):1617-26.","journal-title":"Arch Pharm Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2018.11.022","type":"journal-article","article-title":"Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy","volume":"293","author":"Guan","year":"2019","unstructured":"Guan X, Lin L, Chen J, Hu Y, Sun P, Tian H, et al. Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy. J Control Release. 2019;293:104-12.","journal-title":"J Control Release"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.cell.2021.02.011","type":"journal-article","article-title":"Understanding and treating the inflammatory adverse events of cancer immunotherapy","volume":"184","author":"Dougan","year":"2021","unstructured":"Dougan M, Luoma AM, Dougan SK, Wucherpfennig KW. Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 2021;184(6):1575-88.","journal-title":"Cell"},{"issue":"17","key":"ref30","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","type":"journal-article","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","unstructured":"Postow MA, Callahan MK, Wolchok JD. Immune checkpoint blockade in cancer therapy. J Clin Oncol. 2015;33(17):1974-82.","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"ref31","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1194\/jlr.R800073-JLR200","type":"journal-article","article-title":"Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease","volume":"50","author":"Merrill","year":"2009","unstructured":"Merrill AH Jr, Stokes TH, Momin A, Park H, Portz BJ, Kelly S, et al. Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J Lipid Res. 2009;50 Suppl:S97-102.","journal-title":"J Lipid Res"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1194\/jlr.M800319-JLR200","type":"journal-article","article-title":"Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer","volume":"49","author":"Kiebish","year":"2008","unstructured":"Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res. 2008;49(12):2545-56.","journal-title":"J Lipid Res"},{"issue":"37","key":"ref33","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.1310894110","type":"journal-article","article-title":"Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity","volume":"110","author":"Benjamin","year":"2013","unstructured":"Benjamin DI, Cozzo A, Ji X, Roberts LS, Louie SM, Mulvihill MM, et al. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. Proc Natl Acad Sci U S A. 2013;110(37):14912-7.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7360","key":"ref34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","type":"journal-article","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","unstructured":"Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476(7360):346-50.","journal-title":"Nature"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.tips.2019.09.006","type":"journal-article","article-title":"Combating human pathogens and cancer by targeting phosphoinositides and their metabolism","volume":"40","author":"Phan","year":"2019","unstructured":"Phan TK, Bindra GK, Williams SA, Poon IKH, Hulett MD. Combating human pathogens and cancer by targeting phosphoinositides and their metabolism. Trends Pharmacol Sci. 2019;40(11):866-82.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11306-019-1555-9","type":"journal-article","article-title":"Recognition of early and late stages of bladder cancer using metabolites and machine learning","volume":"15","author":"Kouznetsova","year":"2019","unstructured":"Kouznetsova VL, Kim E, Romm EL, Zhu A, Tsigelny IF. Recognition of early and late stages of bladder cancer using metabolites and machine learning. Metabolomics. 2019;15(7):94.","journal-title":"Metabolomics"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/10409238.2012.735643","type":"journal-article","article-title":"The role of phosphatidylcholine and choline metabolites to cell proliferation and survival","volume":"48","author":"Ridgway","year":"2013","unstructured":"Ridgway ND. The role of phosphatidylcholine and choline metabolites to cell proliferation and survival. Crit Rev Biochem Mol Biol. 2013;48(1):20-38.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00216-013-7062-3","type":"journal-article","article-title":"Imaging mass spectrometry distinguished the cancer and stromal regions of oral squamous cell carcinoma by visualizing phosphatidylcholine (16:0\/16:1) and phosphatidylcholine (18:1\/20:4)","volume":"406","author":"Uchiyama","year":"2014","unstructured":"Uchiyama Y, Hayasaka T, Masaki N, Watanabe Y, Masumoto K, Nagata T, et al. Imaging mass spectrometry distinguished the cancer and stromal regions of oral squamous cell carcinoma by visualizing phosphatidylcholine (16:0\/16:1) and phosphatidylcholine (18:1\/20:4). Anal Bioanal Chem. 2014;406(5):1307-16.","journal-title":"Anal Bioanal Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","type":"journal-article","article-title":"Phosphatidylethanolamine metabolism in health and disease","volume":"321","author":"Calzada","year":"2016","unstructured":"Calzada E, Onguka O, Claypool SM. Phosphatidylethanolamine metabolism in health and disease. Int Rev Cell Mol Biol. 2016;321:29-88.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.4049\/jimmunol.148.7.2207","type":"journal-article","article-title":"Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages","volume":"148","author":"Fadok","year":"1992","unstructured":"Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148(7):2207-16.","journal-title":"J Immunol"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1006\/excr.1997.3521","type":"journal-article","article-title":"Exposure of phosphatidylethanolamine on the surface of apoptotic cells","volume":"232","author":"Emoto","year":"1997","unstructured":"Emoto K, Toyama-Sorimachi N, Karasuyama H, Inoue K, Umeda M. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp Cell Res. 1997;232(2):430-4.","journal-title":"Exp Cell Res"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1172\/JCI200114122","type":"journal-article","article-title":"Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences","volume":"108","author":"Fadok","year":"2001","unstructured":"Fadok VA, Bratton DL, Henson PM. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest. 2001;108(7):957-62.","journal-title":"J Clin Invest"},{"issue":"21","key":"ref43","first-page":"6132","type":"journal-article","article-title":"Increased exposure of anionic phospholipids on the surface of tumor blood vessels","volume":"62","author":"Ran","year":"2002","unstructured":"Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 2002;62(21):6132-40.","journal-title":"Cancer Res"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1158\/1078-0432.CCR-04-1645","type":"journal-article","article-title":"Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice","volume":"11","author":"Ran","year":"2005","unstructured":"Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe PE. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin Cancer Res. 2005;11(4):1551-62.","journal-title":"Clin Cancer Res"},{"issue":"22","key":"ref45","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1158\/1078-0432.CCR-09-1499","type":"journal-article","article-title":"Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma","volume":"15","author":"He","year":"2009","unstructured":"He J, Yin Y, Luster TA, Watkins L, Thorpe PE. Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin Cancer Res. 2009;15(22):6871-80.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1593\/neo.101366","type":"journal-article","article-title":"Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium","volume":"13","author":"Stafford","year":"2011","unstructured":"Stafford JH, Thorpe PE. Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. Neoplasia. 2011;13(4):299-308.","journal-title":"Neoplasia"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0360-3016(02)03928-7","type":"journal-article","article-title":"Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy","volume":"54","author":"Ran","year":"2002","unstructured":"Ran S, Thorpe PE. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiat Oncol Biol Phys. 2002;54(5):1479-84.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1194\/jlr.M031989","type":"journal-article","article-title":"Phosphatidylserine synthase 2: high efficiency for synthesizing phosphatidylserine containing docosahexaenoic acid","volume":"54","author":"Kimura","year":"2013","unstructured":"Kimura AK, Kim HY. Phosphatidylserine synthase 2: high efficiency for synthesizing phosphatidylserine containing docosahexaenoic acid. J Lipid Res. 2013;54(1):214-22.","journal-title":"J Lipid Res"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/2211-5463.13231","type":"journal-article","article-title":"Optimization of a modeling platform to predict oncogenes from genome-scale metabolic networks of non-small-cell lung cancers","volume":"11","author":"Wang","year":"2021","unstructured":"Wang YT, Lin MR, Chen WC, Wu WH, Wang FS. Optimization of a modeling platform to predict oncogenes from genome-scale metabolic networks of non-small-cell lung cancers. FEBS Open Bio. 2021;11(8):2078-94.","journal-title":"FEBS Open Bio"},{"issue":"5","key":"ref50","first-page":"1353","type":"journal-article","article-title":"Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer","volume":"20","author":"Bepler","year":"2002","unstructured":"Bepler G, Gautam A, McIntyre LM, Beck AF, Chervinsky DS, Kim YC, et al. Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. J Clin Oncol. 2002;20(5):1353-60.","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref51","first-page":"58","type":"journal-article","article-title":"Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets","volume":"20","author":"Luan","year":"2020","unstructured":"Luan M, Song F, Qu S, Meng X, Ji J, Duan Y, et al. Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets. Oncol Lett. 2020;20(4):58.","journal-title":"Oncol Lett"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"e47537","DOI":"10.1371\/journal.pone.0047537","type":"journal-article","article-title":"Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases","volume":"7","author":"Wikman","year":"2012","unstructured":"Wikman H, Sielaff-Frimpong B, Kropidlowski J, Witzel I, Milde-Langosch K, Sauter G, et al. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases. PLoS One. 2012;7(10):e47537.","journal-title":"PLoS One"},{"issue":"5","key":"ref53","first-page":"440","type":"journal-article","article-title":"Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy","volume":"53","author":"Kozlowski","year":"2006","unstructured":"Kozlowski L, Filipowski T, Rucinska M, Pepinski W, Janica J, Skawronska M, et al. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy. Neoplasma. 2006;53(5):440-3.","journal-title":"Neoplasma"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/onc.2012.596","type":"journal-article","article-title":"TRIM3, a tumor suppressor linked to regulation of p21(Waf1\/Cip1)","volume":"33","author":"Liu","year":"2014","unstructured":"Liu Y, Raheja R, Yeh N, Ciznadija D, Pedraza AM, Ozawa T, et al. TRIM3, a tumor suppressor linked to regulation of p21(Waf1\/Cip1). Oncogene. 2014;33(3):308-15.","journal-title":"Oncogene"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<232::AID-CNCR5>3.0.CO;2-S","type":"journal-article","article-title":"Allelic deletion in 11p15 is a common occurrence in esophageal and gastric adenocarcinoma","volume":"83","author":"Moskaluk","year":"1998","unstructured":"Moskaluk CA, Rumpel CA. Allelic deletion in 11p15 is a common occurrence in esophageal and gastric adenocarcinoma. Cancer. 1998;83(2):232-9.","journal-title":"Cancer"},{"issue":"10","key":"ref56","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","type":"journal-article","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez F, Mui\u00f1os F, Sent\u00eds I, Deu-Pons J, Reyes-Salazar I, Arnedo-Pac C, et al. A compendium of mutational cancer driver genes. Nat Rev Cancer. 2020;20(10):555-72.","journal-title":"Nat Rev Cancer"},{"key":"ref57","type":"journal-article","article-title":"Immune microenvironment and immunotherapy in pancreatic cancer: a narrative review","author":"Yu","year":"2021","unstructured":"Yu X, Shi S, Yu X. Immune microenvironment and immunotherapy in pancreatic cancer: a narrative review. Precis Cancer Med. 2021.","journal-title":"Precis Cancer Med"},{"issue":"21","key":"ref58","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1111\/febs.15028","type":"journal-article","article-title":"The influence of microenvironment on tumor immunotherapy","volume":"286","author":"Zhang","year":"2019","unstructured":"Zhang J, Shi Z, Xu X, Yu Z, Mi J. The influence of microenvironment on tumor immunotherapy. FEBS J. 2019;286(21):4160-75.","journal-title":"FEBS J"},{"issue":"18","key":"ref59","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","type":"journal-article","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557-66.","journal-title":"Cancer Res"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115801","type":"journal-article","article-title":"Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review","volume":"22","author":"Oura","year":"2021","unstructured":"Oura K, Morishita A, Tani J, Masaki T. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review. Int J Mol Sci. 2021;22(11).","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/71827\/multi-omics-pan-cancer-bioinformatics-workflow-for-evaluating-ptdss1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:35:31Z","timestamp":1792589731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/71827\/multi-omics-pan-cancer-bioinformatics-workflow-for-evaluating-ptdss1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":60,"journal-issue":{"issue":"232","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/71827","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}